The TB Partnership in 2017 GLOBAL ADVOCACY The Stop TB Partnership is leading global advocacy efforts to put the world on track to ending TB by 2030. We work closely with our 1600 partners to ensure TB is at the top of global political agenda. The Stop TB Partnership led the campaign for governments to hold a UN High-Level Meeting (HLM) on TB. Dr. Motsoaledi as Chair of the Stop TB Partnership Board and Minister of Health, South Africa first called for an HLM on TB at the UN General Assembly in 2016. Together with our partners, we successfully campaigned for TB to be recognized in the G20 Heads of State and Ministers of Health Declaration in 2017, the first time TB has been recognized by the G20. We unite and empower people affected by TB, civil society, and communities by giving them a voice, platforms, and visibility. We coordinate the annual World TB Day on 24th March to raise awareness about the burden of TB globally. The Global Plan to End TB 2016-2020 and the 90/90/90 TB targets, widely endorsed by Heads of State and Health Ministers, drive our work to put TB higher on the political agenda, mobilize resources, and create a paradigm shift in the global TB movement. STRENGTHENING COMMUNITIES People affected by TB and communities must be at the heart of all efforts to end TB. Stop TB works in the following areas: Supporting community engagement through the Challenge Facility for Civil Society (CFCS) a grant programme to support community engagement; ensuring TB programmes are centred on human rights, gender sensitive interventions and increasing access to key underserved and vulnerable populations to quality TB services; and investing in strengthening community systems and responses in global, regional and national platforms. Together with the Global Fund and partners, Stop TB provides support to country programmes. UNITE TO END TB HELP BRING THE TB EPIDEMIC TO AN END TB is the world’s leading infectious disease killer WHO WE ARE The Stop TB Partnership is a unique international body, which is a part of the United Nations family, that aligns all actors over the world to End TB. The Stop TB Partnership ensures a voice for the TB community at the highest levels. Various programmes identify and fund innovative approaches to find, treat and cure people affected by TB. The Stop TB Partnership plays a key role in procuring TB drugs and diagnostics, including the roll-out of new tools across the world. Its market shaping strategy also helps to reduce prices, improve forecasting and prevent stock-outs for drugs.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
The
TB Partnershipin 2017
GLOBAL ADVOCACY
The Stop TB Partnership is leading global advocacy efforts to put the world on track
to ending TB by 2030. We work closely with our 1600 partners to ensure TB is at the top of
global political agenda.
The Stop TB Partnership led the campaign for governments to hold a UN High-Level Meeting (HLM) on TB. Dr. Motsoaledi
as Chair of the Stop TB Partnership Board and Minister of Health, South Africa first called for an HLM on TB at the UN General
Assembly in 2016. Together with our partners, we successfully campaigned for TB to be recognized in the G20 Heads of State
and Ministers of Health Declaration in 2017, the first time TB has been recognized by the G20. We unite and empower people
affected by TB, civil society, and communities by giving them a voice, platforms, and visibility. We coordinate the annual World
TB Day on 24th March to raise awareness about the burden of TB globally. The Global Plan to End TB 2016-2020 and the 90/90/90 TB targets, widely endorsed by Heads of State and
Health Ministers, drive our work to put TB higher on the political agenda, mobilize resources, and create a paradigm shift in the
global TB movement.
STRENGTHENING COMMUNITIES
People affected by TB and communities must be at the heart of all efforts to end TB.
Stop TB works in the following areas: Supporting community engagement through the Challenge Facility for Civil Society
(CFCS) a grant programme to support community engagement; ensuring TB programmes are centred
on human rights, gender sensitive interventions and increasing access to key underserved and vulnerable populations to quality TB services;
and investing in strengthening community systems and responses in global, regional
and national platforms. Together with the Global Fund and partners, Stop
TB provides support to country programmes.
UNITE TO
END TBHELP BRING
THE TB EPIDEMIC TO AN END
TB is the world’s leading infectious disease killer
WHO WE ARE
The Stop TB Partnership is a unique international body, which is a part of the United Nations family, that aligns all actors over the world to End TB.
The Stop TB Partnership ensures a voice for the TB community at the highest levels.
Various programmes identify and fund innovative approaches to find, treat and cure people affected by TB.
The Stop TB Partnership plays a key role in procuring TB drugs and diagnostics, including the roll-out of new tools across the world. Its market shaping strategy also helps to reduce prices, improve forecasting and prevent stock-outs for drugs.
KEY ACHIEVEMENTS
www.stoptb.org
TB REACH GLOBAL DRUG FACILITY
STRATEGIC INITIATIVES & INNOVATIVE FINANCING
DONORS IN 2017
• Countries Affected by TB• TB-Affected Communities• Developing Country
Non-Governmental Organization
• Developed Country Non-Governmental Organization
• Donors• Foundations• Multi-Lateral Organizations• Private Sector• Technical Agencies• Working Groups• Open Seats
BOARD COMPOSITION
SE
CR
ET
AR
IAT
• Global Drug-resistant TB Initiative (GDI)• Global Laboratory Initiative (GLI)• End TB Transmission initiative (ETT)• Public-Private Mix (PPM) for TB Care And Control• Child and Adolescent TB Working Group• TB/HIV Working Groups• New Diagnostics Working Group (NDWG)• Working Group on New Drugs (WGND)• Working Group on New Vaccines (WGNV)
WORKING GROUPS
GLOBAL TB CAUCUS
National platforms in 27 countriesNATIONAL PLATFORMS
5 regionsGLOBAL COALITION OF TB ACTIVITS (GCTA)
2 regionsPEOPLE AFFECTED BY TB
STOP TB PARTNERSHIP STRUCTURES
TB REACH is a multi-lateral funding mecha-nism which provides grants to partners for testing innovative strategies and technolo-gies aimed at increasing the number of people diagnosed and treated for tuberculosis (TB), decreasing the time to appropriate treatment and improving treatment success.
TB REACH combines fast-track, results-based financing and rigorous, external monitoring and evaluation (M&E) to produce results, so national governments and/or other donor agencies can scale up successful approaches and maximize their own investments.
Strategic Initiatives & Innovative Financing’s (SIIF) primary mission is to develop and launch inno-vative projects that:
(1) promotes cross-sectoral collaboration and(2) leverages the business sector’s expertise and resources.
As such, it created a venture lab (vLAB) fund to pool and blend both private and public sector capital to seed entrepreneurial ideas to solve challenging and systemic problems in the global health and TB space. The first project launched, together with FIND, McGill International TB Centre, Unitaid, and TB Proof, is the Accelerator for Impact (a4i) which is a coordination platform of key partners and activities that focuses on the downstream end of the product development lifecycle and executes an efficient pathway to rapidly roll-out promising, new TB tools.
The Global Drug Facility (GDF) is a one-stop, bundled procurement and supply mechanism for quality assured TB health products aimed at facilitating world-wide, equitable access to TB medicines and diagnostics across both public and private sectors.
Global Drug Facility combines strategic procure-ment and innovative logistics solutions, man-agement and coordination of market activities for the full portfolio of TB medicines and diag-nostics, technical assistance and capacity build-ing for TB programmes in better pharmaceutical management practices, and accelerated uptake of new TB medicines, regimens, and diagnostics.
The Stop TB Partnership’s work is made possible only through the support of the Partnership’s many funders and partners. We appreciate their trust and gratefully acknowledge their support.
Bill & Melinda Gates FoundationEli Lilly & Co.Global Affairs CanadaThe Global Fund to Fight AIDS, Tuberculosis and MalariaIndonesian Health FundKochon FoundationUNITAIDUnited Nations FoundationUSAIDUS Centers for Disease Control and Prevention
DELIVERED TB DRUGS29.7 million adult TB treatments 1.8 million pediatric TB treatments 258, 006 treatments for drug resistant TB
PROCURED TB DIAGNOSTICSworth US$ 173 million for more than 93 countries
ENSUREDBedaquiline, delamanid and new pediatric formulations are availableA stable and competitive supplier base
GDF (Global Drug Facility)Between 2001 and mid-2017
AWARDED (CHALLENGE FACILITY)131 grants through 7 rounds strengthening grass roots community systems
DEVELOPED & IMPLEMENTEDTB Gender Assessment Tool, 10 Key Population Guides, a Legal Environment Assessment Tool and a TB Law Case Compendium
STRENGTHENED TB SURVIVOR NETWORKS4 regional and 56 national networks of people affected by TB
TRAINING AND IMPLEMENTATION OF THE TB/HIV GENDER ASSESSMENT TOOLthe Legal Environment Assessment Tool and the Action Framework for Key, Vulnerable and Underserved Populations is underway and being rolled out in several high burden countries.
STRENGTHENING COMMUNITIESBetween 2007 and 2017ADVOCACY (High Level)
LAUNCHED THE GLOBAL PLAN TO END TB and the 90-(90)-90 TB targets
SECURED Heads of States commitment to increase TB financing and achieving the 90-(90)-90 targets
CHAIR OF THE BOARD LAUNCHED and led successful campaign for a UN HLM on TB
G20 HEADS OF STATE RECOGNIZED TB as a key priority and G20 Health Minister’s recognized the lead role of the Stop TB Partnership
TB REACHBetween 2010 and through 2016
PROVIDED180 grants in 49 countries for US$ 111 million
OUR TB REACH GRANTEES DIAGNOSED AND TREATEDOver 2 million people with TB, saving 900, 000 lives in the most underserved populations while working in close collaboration with National TB Programmes.
TB REACH REPLENISHEDfor nearly CAD 100 million for 2016-2020.
Related Documents
